Cancer Immunotherapy

March 18, 2020 | by BioVox

The BioVox White Paper on Cancer Immunotherapy showcases innovators and world leaders in this exciting field, including GSK Biologicals, Janssen Immunosciences, Celyad, RXi Pharmaceuticals, eTheRNA, ImmunXperts, iTeos Therapeutics and PDC*line Pharma.

In this issue:

– Why is immunotherapy more than the latest hype?
– What are the challenges to bring lifesaving innovations to the patient?
– The price of life: who will pay for these treatments?
– Pioneering immunotherapy companies in the picture
– Insight in landmark oncology trials
– Academic innovations in immunotherapy

Download white paper for free

You will receive a link, immediately after submitting this form.

The BioVox platform is completely free! The only thing we ask in return is a bit more information about you and your fields of interest. This will allow us to provide more personalized information in the future.